Announcements Trials
Browse Landscape

Phase

Phase 2 23Phase 1 15Phase 1/2 12Phase 3 2Phase NA 1Phase EARLY_PHASE1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 8Colorectal Neoplasms 7Carcinoma, Hepatocellular 7Carcinoma, Non-Small-Cell Lung 5Brain Neoplasms 5Rectal Neoplasms 4Glioma 4Breast Neoplasms 4Neoplasms 3Meningeal Carcinomatosis 3Lung Neoplasms 3Colonic Neoplasms 3Ovarian Neoplasms 2Melanoma 2Hypertension 2Carcinoma, Renal Cell 2Breast Neoplasms, Male 2Uveal Melanoma 1Recurrence 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Neoplasms, Nerve Tissue 1Neoplasm Metastasis 1Multi-organ Metastatic Colorectal Cancer 1Liver Neoplasms 1Fallopian Tube Neoplasms 1Central Nervous System Neoplasms 1Biliary Tract Neoplasms 1Advanced Non-squamous Non-Small Cell Lung Cancer 1

Interventions

Standard of Care 18Gemcitabine 18Radiosurgery 14Drug Therapy 13Blood Specimen Collection 13Endoscopic Ultrasound-Guided Fine Needle Aspiration 11Exercise 10Pancreaticoduodenectomy 9Practice Guidelines as Topic 8Methods 8Magnetic Resonance Spectroscopy 8Biopsy, Fine-Needle 8Capecitabine 7Early Intervention, Educational 6Biopsy 6Surveys and Questionnaires 5Stents 5Specimen Handling 5Resistance Training 5Radiofrequency Ablation 5Psychiatric Rehabilitation 5Oxaliplatin 5Fluorouracil 5Cholangiopancreatography, Endoscopic Retrograde 5130-nm albumin-bound paclitaxel 5Secretin 4Radiotherapy 4Irinotecan 4Heavy Ion Radiotherapy 4Electroporation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Pancreatic Neoplasms × Bevacizumab × Clear all
NCT00524069 2013-02-01

Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery

Roswell Park Cancer Institute

Phase NA Withdrawn
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡